Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRVS is expected to report earnings to fall 34.72% to -11 cents per share on May 01

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q1'25

Est.

$-0.12

Q4'24

Missed

by $0.06

Q3'24

Missed

by $0.49

Q2'24

Beat

by $0.05

Q1'24

Est.

$-0.12

The last earnings report on March 25 showed earnings per share of -18 cents, missing the estimate of -11 cents. With 9.35K shares outstanding, the current market capitalization sits at 218.72M.

View a ticker or compare two or three

Compare

CRVS